These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22747464)

  • 1. Multiplex immunoassays: an invaluable tool for biomarker discovery and validation.
    Lehr S
    Arch Physiol Biochem; 2012 Oct; 118(4):191. PubMed ID: 22747464
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithm development for diagnostic biomarker assays.
    Izmailov R; Guest PC; Bahn S; Schwarz E
    Int Rev Neurobiol; 2011; 101():279-98. PubMed ID: 22050856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays.
    Rai AJ
    Expert Rev Mol Diagn; 2007 Sep; 7(5):545-53. PubMed ID: 17892363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex assays for biomarker research and clinical application: translational science coming of age.
    Fu Q; Schoenhoff FS; Savage WJ; Zhang P; Van Eyk JE
    Proteomics Clin Appl; 2010 Mar; 4(3):271-84. PubMed ID: 21137048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User configurable microfluidic device for multiplexed immunoassays based on DNA-directed assembly.
    Schroeder H; Adler M; Gerigk K; Müller-Chorus B; Götz F; Niemeyer CM
    Anal Chem; 2009 Feb; 81(3):1275-9. PubMed ID: 19123774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic homo- and hetero-geneous immunoassays: a tool to accelerate protein biomarker development.
    Karns K; Herr AE
    Bioanalysis; 2011 Oct; 3(19):2161-5. PubMed ID: 21985410
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis.
    Eastman PS; Manning WC; Qureshi F; Haney D; Cavet G; Alexander C; Hesterberg LK
    J Pharm Biomed Anal; 2012 Nov; 70():415-24. PubMed ID: 22749821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker assay development and validation for large molecules in bioanalysis: what are the challenges and how are they overcome?
    Stevenson LF
    Bioanalysis; 2012 Nov; 4(22):2657-9. PubMed ID: 23210647
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms.
    Jayadev C; Rout R; Price A; Hulley P; Mahoney D
    J Immunol Methods; 2012 Dec; 386(1-2):22-30. PubMed ID: 22955210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin is not a valid biomarker when measured in saliva by immunoassay.
    Horvat-Gordon M; Granger DA; Schwartz EB; Nelson VJ; Kivlighan KT
    Physiol Behav; 2005 Mar; 84(3):445-8. PubMed ID: 15763582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex assays of inflammatory markers, a description of methods and discussion of precautions - Our experience through the last ten years.
    Skogstrand K
    Methods; 2012 Feb; 56(2):204-12. PubMed ID: 22001645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microspot immunoassay-based analysis of plasma protein profiles for biomarker discovery strategies.
    Sonntag J; Mannsperger H; Jöcker A; Korf U
    Methods Mol Biol; 2011; 785():237-45. PubMed ID: 21901604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioanalytical interferences in immunoassays for antibody biotherapeutics.
    Pendley C; Shankar G
    Bioanalysis; 2011 Apr; 3(7):703-6. PubMed ID: 21452985
    [No Abstract]   [Full Text] [Related]  

  • 15. Mass spectrometry-based immunoassays for the next phase of clinical applications.
    Nedelkov D
    Expert Rev Proteomics; 2006 Dec; 3(6):631-40. PubMed ID: 17181477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based protein assays for in vitro diagnostic testing.
    Nedelkov D
    Expert Rev Mol Diagn; 2012 Apr; 12(3):235-9. PubMed ID: 22468814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid development of novel protein biomarkers using real-time immunoassays.
    Houle JF
    Bioanalysis; 2010 Jun; 2(6):991-3. PubMed ID: 21083200
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiplex ready flow cytometric immunoassay for total insulin like growth factor 1 in serum of cattle.
    Bremer MG; Smits NG; Haasnoot W; Nielen MW
    Analyst; 2010 May; 135(5):1147-52. PubMed ID: 20419268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct.
    Kiernan UA; Nedelkov D; Nelson RW
    J Proteome Res; 2006 Nov; 5(11):2928-34. PubMed ID: 17081044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The measurement of cardiac markers: where should we focus?
    Panteghini M
    Am J Clin Pathol; 2002 Sep; 118(3):354-61. PubMed ID: 12219777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.